These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3037168)

  • 1. Risks of angiotensin converting enzyme inhibition in renal artery stenosis.
    Wenting GJ; Derkx FH; Tan-Tjiong LH; van Seyen AJ; Man in't Veld AJ; Schalekamp MA
    Kidney Int Suppl; 1987 May; 20():S180-3. PubMed ID: 3037168
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects on angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis.
    Levenson DJ; Dzau VJ
    Kidney Int Suppl; 1987 May; 20():S173-9. PubMed ID: 3037167
    [No Abstract]   [Full Text] [Related]  

  • 3. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney.
    Hricik DE; Browning PJ; Kopelman R; Goorno WE; Madias NE; Dzau VJ
    N Engl J Med; 1983 Feb; 308(7):373-6. PubMed ID: 6337327
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
    Plante GE; Chainey A; Sirois P; Devissaguet M
    J Hypertens Suppl; 1988 Dec; 6(3):S69-73. PubMed ID: 3066878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deterioration of renal function after converting enzyme inhibition in a patient with renal artery stenosis after transplantation.
    Van Son WJ; Donker AJ; Van der Woude FJ; Meijer S; Slooff MJ; Tegzess AM; Van der Slikke LB
    Neth J Med; 1984; 27(1):10-3. PubMed ID: 6324009
    [No Abstract]   [Full Text] [Related]  

  • 6. Converting enzyme-induced reversible deterioration of renal function in a patient with unilateral renal artery stenosis.
    Kremer Hovinga TK; Donker AJ; Piers DA
    Clin Nephrol; 1984 Aug; 22(2):106-7. PubMed ID: 6090045
    [No Abstract]   [Full Text] [Related]  

  • 7. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reversible acute renal insufficiency caused by converting enzyme inhibitors in a patient with mesangial glomerulonephritis].
    Guérin C; Berthoux P; Berthoux FC
    Nephrologie; 1987; 8(6):307-8. PubMed ID: 2837670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure, renal function, and angiotensin converting enzyme inhibitors.
    Cleland JG; Dargie HJ
    Kidney Int Suppl; 1987 May; 20():S220-8. PubMed ID: 3037173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determinant factors in the acute functional deterioration caused by the inhibition of the conversion enzyme in reno-vascular arterial hypertension].
    Ribstein J; Mourad G; Mimran A
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):866-9. PubMed ID: 3116987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does captopril reduce renal function in renovascular disease by postglomerular vasodilatation?
    Schwietzer G; Laass C; Kampf D; Bähr V; Schultze G; Molzahn M; Distler A
    J Hypertens Suppl; 1985 Nov; 3(2):S139-41. PubMed ID: 3910770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
    Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
    J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdependence of food intake and angiotensin converting enzyme inhibition on kidney function.
    Corman B; Michel JB
    J Hypertens Suppl; 1988 Dec; 6(3):S65-8. PubMed ID: 3225691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril and renal autoregulation.
    Blythe WB
    N Engl J Med; 1983 Feb; 308(7):390-1. PubMed ID: 6337329
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlation of renin-angiotensin system and prostanoids system in renal circulation: dissociation of renal blood flow and glomerular filtration rate in acute alterations of renal blood pressure].
    Goto F
    Masui; 1984 Nov; 33(11):1204-12. PubMed ID: 6394780
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal physiology of renal artery stenosis. Implications for captopril-stimulated renography.
    Nally JV
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):669S-674S. PubMed ID: 1777181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal insufficiency after administration of captopril in renal artery stenosis with a single kidney or bilateral stenosis is not compulsory].
    Durand D; Tran Van T; Ader JL; Suc JM
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1272-7. PubMed ID: 6441547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.
    Curtis JJ; Luke RG; Whelchel JD; Diethelm AG; Jones P; Dustan HP
    N Engl J Med; 1983 Feb; 308(7):377-81. PubMed ID: 6337328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.